NCT07016191

Brief Summary

Therapeutic delivery of additional Oxygen to blood stream via hyperbaric and extracorporeal oxygenation that raises blood Oxygen saturation level, apart from oxygenation in the lungs, is known to induce tissue repair, restore normal body functions and improve survival. Despite the clinical benefits obtained from these interventions, Oxygen supplementation is rather a medically involved process requiring access to specialized equipment including hyperbaric chambers, cardiac catheterization laboratory and extracorporeal oxygenators, and is not generally amenable for everyday use. The current prospective study will evaluate a non-invasive route for Oxygen delivery through ingestion of super-oxygenated water in adult volunteers. The participants will be randomly assigned to one of the two study groups viz. Inhale super-oxygenated water or placebo control normal water at 1:1 ratio. Neither the participants nor the study doctor will know the treatment assignment. Pre- and post-ingestion measurements will be conducted to evaluate effect of super-oxygenated water.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

May 16, 2025

Completed
26 days until next milestone

First Posted

Study publicly available on registry

June 11, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 26, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2025

Completed
2 months until next milestone

Results Posted

Study results publicly available

January 27, 2026

Completed
Last Updated

January 27, 2026

Status Verified

January 1, 2026

Enrollment Period

7 months

First QC Date

May 16, 2025

Results QC Date

December 2, 2025

Last Update Submit

January 8, 2026

Conditions

Keywords

InhaleSuper-oxygenated WaterSuperoxygenated WaterBlood Oxygen Saturation

Outcome Measures

Primary Outcomes (2)

  • SpO2 Response Rate

    Number of participants who experienced an improvement in post-ingestion SpO2. An increase in post-ingestion SpO2 over the pre-ingestion level in the same subject was considered a response.

    From pre-ingestion to post-ingestion of water

  • Heart Rate Response Rate

    Number of participants who experienced a reduction in post-ingestion heart rate. A decrease in post-ingestion heart rate over the pre-ingestion level in the same subject was considered a response.

    From pre-ingestion to post-ingestion of water

Secondary Outcomes (2)

  • Energy Level Response Rate

    From pre-ingestion to post-ingestion of water

  • Brain Clarity Response Rate

    From pre-ingestion to post-ingestion of water

Study Arms (2)

Inhale Water

EXPERIMENTAL

Participants will ingest 12oz of Inhale Super-Oxygenated water

Other: Ingestion of Water

Normal Water

PLACEBO COMPARATOR

Participants will ingest 12oz of Source and Taste-matched normal water

Other: Ingestion of Water

Interventions

Ingestion of Super-Oxygenated or Normal water

Inhale WaterNormal Water

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Legally adult (18 years of age or older)
  • Subject must be willing to review and provide a written informed consent
  • Subject must agree to the study procedures including water ingestion, and SPO2 and heart rate measurements

You may not qualify if:

  • Any active and life-threatening medical condition involving hepatic, renal, cardiac, respiratory, endocrine, or gastrointestinal systems, or any blood disorder in view of the Principal Investigator to confound the study
  • Female subjects those are pregnant, nursing or planning to become pregnant
  • Subjects receiving any experimental medications or have undergone a major surgical procedure in last 30 days
  • Subjects are excluded if they have previously utilized the test article (INHALE superoxygenated water) within the last 24 hours, or have undergone bariatric surgery or have received weight-loss medication
  • Subjects with known anemia, hemoglobinopathy or other comorbidity necessitating fluid restriction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Center For Whole Health

Westlake Village, California, 91362, United States

Location

MeSH Terms

Conditions

Respiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Ian Mitchell
Organization
Inhale Inc

Study Officials

  • Deepak Nayak, PhD

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2025

First Posted

June 11, 2025

Study Start

May 1, 2025

Primary Completion

November 26, 2025

Study Completion

November 28, 2025

Last Updated

January 27, 2026

Results First Posted

January 27, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

The results will be utilized in business decisions and possible publications. At this point the data may or may not be shared.

Locations